Staurosporine Induced Apoptosis Rapidly Downregulates TDP-43 in Glioma Cells

  • Nan, Yi-Nan (School of Preclinical Medicine, Center Laboratory, Beijing University of Chinese Medicine) ;
  • Zhu, Jing-Yan (Brain Research Centre, University of British Columbia) ;
  • Tan, Yan (School of Preclinical Medicine, Center Laboratory, Beijing University of Chinese Medicine) ;
  • Zhang, Qi (School of Preclinical Medicine, Center Laboratory, Beijing University of Chinese Medicine) ;
  • Jia, William (Brain Research Centre, University of British Columbia) ;
  • Hua, Qian (School of Preclinical Medicine, Center Laboratory, Beijing University of Chinese Medicine)
  • Published : 2014.04.30


TDP-43 is a ubiquitously expressed DNA/RNA binding protein that has recently attracted attention for its involvement in neurodegenerative diseases. While TDP-43 has been found to participate in various important cellular activities including stress and apoptosis, little is known about its role in cancer cells. Here we report that staurosporine (STS) induced apoptosis in U87 glioma cells is associated with rapid downregulation of TDP-43 at both mRNA and protein levels. The latter is dependent on activation of caspase 3. More importantly, we have shown that knockdown of TDP-43 by specific siRNA dramatically enhanced cytotoxicity of STS. These results suggest that normal level of TDP-43 may be protective for cancer cells under apoptotic insult.


  1. Wils H, Kleinberger G, Janssens J, et al (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. P Natl Acad Sci USA, 107, 3858-63.
  2. Slee E, Zhu H, Chow S, et al (1996). Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD. FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J, 315, 21-4.
  3. Sreedharan J, Blair IP, Tripathi VB, et al (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 319, 1668-72.
  4. Wang HY, Wang IF, Bose J, Shen CKJ (2004). Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics, 83, 130-9.
  5. Yamashita T, Hideyama T, Hachiga K, et al (2012). A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat Commun, 3, 1307.
  6. Zhang YJ, Xu YF, Dickey CA, et al (2007). Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci, 27, 10530-4.
  7. Zhang YJ, Xu YF, Cook C, et al (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. P Natl Acad Sci USA, 106, 7607-12.
  8. Zhong D, Ran JH, Tang WY, et al (2012). Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling. Asian Pac J Cancer Prev, 13, 2897-901.
  9. Liu ZM, Wang YB, Yuan XH (2013). Exosomes from murinederived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+ T cells. Asian Pac J Cancer Prev, 14, 309.
  10. Fiesel FC, Voigt A, Weber SS, et al (2009). Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J, 29, 209-21.
  11. Freibaum BD, Chitta RK, High AA, Taylor JP. (2010). Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res, 9, 1104-20.
  12. Goodenberger ML, Jenkins RB (2012). Genetics of adult glioma. Cancer Genet, 205, 613-21.
  13. Luo Y, Wang F, Chen LA, et al (2011). Deregulated expression of cry1 and cry2 in human gliomas. Asian Pac J Cancer Prev, 13, 5725-8.
  14. Mercado PA, Ayala YM, Romano M, Buratti E, Baralle FE (2005). Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res, 33, 6000-10.
  15. McDonald KK, Aulas A, Destroismaisons L, et al (2011). TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet, 20, 1400-10.
  16. Neumann M, Sampathu DM, Kwong LK, et al (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-3.
  17. Nishimoto Y, Ito D, Yagi T, et al (2010). Characterization of alternative isoforms and inclusion body of the TAR DNAbinding protein-43. J Biol Chem, 285, 608-19.
  18. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol, 69, 3584-96.
  19. Buratti E, Baralle FE (2008). Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci, 13, 867-78.
  20. Buratti E, Dörk T, Zuccato E, et al (2001). Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J, 20, 1774-84.
  21. Buratti E, Brindisi A, Pagani F, Baralle FE (2004). Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet, 74, 1322.
  22. Buratti E, Brindisi A, Giombi M, et al (2005). TDP-43 binds heterogeneous nuclear ribonucleoprotein a/b through its c-terminal tail an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem, 280, 37572-84.
  23. Bentmann E, Neumann M, Tahirovic S, et al (2012). Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem, 287, 23079-94.
  24. Cassel JA, McDonnell ME, Velvadapu V, Andrianov V, Reitz AB. (2012). Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function. Biochimie, 94, 1974-81.
  25. Dormann D, Capell A, Carlson AM, et al (2009). Proteolytic processing of TAR DNA binding protein -43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J Neurochem, 110, 1082-94.
  26. Dewey CM, Cenik B, Sephton CF, et al (2011). TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol, 31, 1098-108.
  27. Forman MS, Trojanowski JQ, Lee VMY (2007). TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol, 17, 548-55.
  28. Ayala YM, Laura De Conti S, Vazquez AD, et al (2010). TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J, 30, 277-88.
  29. Ayala YM, Pantano S, D’Ambrogio A, et al (2005). Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol, 348, 575-88.
  30. Ayala YM, Pagani F, Baralle FE (2006). TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett, 580, 1339-44.
  31. Ayala YM, Misteli T, Baralle FE (2008). TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. P Natl Acad Sci USA, 105, 3785-9.
  32. Bertrand R, Solary E, O’Connor P, Kohn KW, Pommier Y (1994). Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res, 211, 314-21.

Cited by

  1. RNA-binding proteins as molecular links between cancer and neurodegeneration vol.15, pp.6, 2014,
  2. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3 vol.115, pp.15, 2018,